Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BRIAN R WEBSTER

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1124129671
CMS profile
187421
Location
WILMINGTON, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,614.26

105 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,388.26 104
Gift $226.00 1

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 3; records 101–105 of 105 matching records. This page contains 5 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BRIAN R WEBSTER

NPI 1124129671 · CMS profile ID 187421

Allopathic & Osteopathic Physicians / Internal Medicine

WILMINGTON, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–105 of 105 matching records. This page contains 5 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1124129671?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BRIAN R WEBSTER, NPI 1124129671, CMS profile ID 187421. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–105 of 105 matching records. This page contains 5 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1124129671?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). BRIAN R WEBSTER, NPI 1124129671, CMS profile ID 187421. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–105 of 105 matching records. This page contains 5 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1124129671?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
BRIAN R WEBSTER, NPI 1124129671, CMS profile ID 187421, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–105 of 105 matching records. This page contains 5 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1124129671?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

105 matching records · $1,614.26 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 105 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–105 of 105.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $10.4201/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673056425 CMS
AstraZeneca Pharmaceuticals LP $10.8501/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685150781 CMS
PFIZER INC. $13.1901/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673047593 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.0401/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700111485 CMS
Dynavax Technologies Corporation $17.4801/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697987519 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,614.26 105
PY2020 $344.12 25
PY2021 $166.49 11
PY2022 $147.76 12
PY2023 $45.48 3

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,179,650.03 45
PY2024 Principal investigator $1,336,794.36 51
PY2023 Recipient $628.25 1
PY2023 Principal investigator $421,175.77 35
PY2022 Principal investigator $414,800.07 178
PY2021 Principal investigator $249,631.83 98
PY2020 Principal investigator $39,638.70 30
PY2019 Principal investigator $10,918.41 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

45 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $3,306.00 12/31/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615621
Principal investigator 1 Genentech, Inc. $400.00 12/19/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615591
Principal investigator 1 Genentech, Inc. $4,223.00 11/21/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615558
Principal investigator 1 Genentech, Inc. $212,772.00 10/17/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615535
Principal investigator 1 Genentech, Inc. $1,508.00 10/10/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615545
Principal investigator 1 Genentech, Inc. $400.00 09/26/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615507
Principal investigator 1 Genentech, Inc. $9,016.00 07/02/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615519
Principal investigator 1 Genentech, Inc. $4,246.50 06/13/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615214
Principal investigator 1 Genentech, Inc. $3,494.00 06/13/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615223
Principal investigator 1 Genentech, Inc. $636.75 06/13/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615303
Principal investigator 1 AstraZeneca Pharmaceuticals LP $88,737.11 06/06/2025 Non-covered Recipient Entity
INNOVO RESEARCH LLC
a phase III,randomised,double blind,placebo controlled,event driven study to assess the efficacy,safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure No dispute reported 06/30/2026 1185552185
Principal investigator 1 Genentech, Inc. $1,508.00 06/04/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615363
Principal investigator 1 Eli Lilly and Company $109.50 05/27/2025 Non-covered Recipient Entity
INNOVO RESEARCH
LONG-TERM REAL-WORLD COMPARATIVE EFFECTIVENESS OF DONANEMAB PLUS USUAL CARE VERSUS USUAL CARE ALONE IN US PATIENTS WITH EARLY SYMPTOMATIC ALZHEIMER'S DISEASE (TRAILBLAZER-REAL US) No dispute reported 06/30/2026 1187882064
Principal investigator 1 Genentech, Inc. $10,556.00 05/23/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615386
Principal investigator 1 Genentech, Inc. $69,847.00 05/16/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615170
Principal investigator 1 Genentech, Inc. $53,649.00 05/14/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615312
Principal investigator 1 Genentech, Inc. $227.25 04/30/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615184
Principal investigator 1 Genentech, Inc. $212,858.00 04/11/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615167
Principal investigator 1 Genentech, Inc. $1,323.52 04/04/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615175
Principal investigator 1 Genentech, Inc. $12,194.00 04/04/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615246
Principal investigator 1 Genentech, Inc. $1,323.52 04/04/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615250
Principal investigator 1 Genentech, Inc. $992.45 04/04/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615266
Principal investigator 1 Genentech, Inc. $947.64 04/04/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615276
Principal investigator 1 Genentech, Inc. $9,524.00 04/04/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615371
Principal investigator 1 Genentech, Inc. $1,143.52 04/04/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615389
Principal investigator 1 Genentech, Inc. $14,377.00 04/04/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615401
Principal investigator 1 Genentech, Inc. $1,987.00 03/12/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211614851
Principal investigator 1 Eli Lilly and Company $33,782.00 03/10/2025 Non-covered Recipient Entity
INNOVO RESEARCH
LONG-TERM REAL-WORLD COMPARATIVE EFFECTIVENESS OF DONANEMAB PLUS USUAL CARE VERSUS USUAL CARE ALONE IN US PATIENTS WITH EARLY SYMPTOMATIC ALZHEIMER'S DISEASE (TRAILBLAZER-REAL US) No dispute reported 06/30/2026 1187883544
Principal investigator 1 Genentech, Inc. $253,574.00 03/05/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211614965
Principal investigator 1 Genentech, Inc. $1,508.00 02/26/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211614841
Principal investigator 1 Genentech, Inc. $1,508.00 02/26/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211614980
Principal investigator 1 Genentech, Inc. $1,322.86 02/26/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615011
Principal investigator 1 Genentech, Inc. $1,508.00 02/21/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211614821
Principal investigator 1 Genentech, Inc. $8,150.00 02/21/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211614977
Principal investigator 1 Alnylam Pharmaceuticals Inc. $17,400.00 02/14/2025 Non-covered Recipient Entity
Innovo Research LLC
A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM No dispute reported 06/30/2026 1215522490
Principal investigator 1 Alnylam Pharmaceuticals Inc. $2,500.00 02/14/2025 Non-covered Recipient Entity
Innovo Research LLC
A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM No dispute reported 06/30/2026 1215522492
Principal investigator 1 Alnylam Pharmaceuticals Inc. $7,010.00 02/14/2025 Non-covered Recipient Entity
Innovo Research LLC
A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM No dispute reported 06/30/2026 1215522494
Principal investigator 1 AstraZeneca Pharmaceuticals LP $9,425.00 02/07/2025 Non-covered Recipient Entity
INNOVO RESEARCH LLC
A Phase III, Randomised, Multicentre, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of Zibotentan/Dapagliflozin FDC Compared to Dapagliflozin Alone in Participants with Chronic Kidney Disease and High Proteinuria No dispute reported 06/30/2026 1185552183
Principal investigator 1 Genentech, Inc. $11,602.14 02/05/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615037
Principal investigator 1 Genentech, Inc. $1,508.00 01/17/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615052
Principal investigator 1 Genentech, Inc. $1,508.00 01/14/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211614996
Principal investigator 1 Genentech, Inc. $1,508.00 01/13/2025 Non-covered Recipient Entity
INNOVO RESEARCH INC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211615020
Principal investigator 1 GlaxoSmithKline, LLC. $2,233.00 01/10/2025 Non-covered Recipient Entity
INNOVO RESEARCH
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO EVALUATE No dispute reported 06/30/2026 1192171613
Principal investigator 1 GlaxoSmithKline, LLC. $1,417.00 01/10/2025 Non-covered Recipient Entity
INNOVO RESEARCH
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO EVALUATE No dispute reported 06/30/2026 1192171618
Principal investigator 1 AstraZeneca Pharmaceuticals LP $100,879.27 01/03/2025 Non-covered Recipient Entity
INNOVO RESEARCH LLC
a phase 3,randomised,double blind,active controlled study to assess the efficacy,safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease ckd progression in participants with ckd and high blood pressure No dispute reported 06/30/2026 1185552187